MAPK1 and neoplasm: In bladder cancer, it inhibits both SNAIL and MAPK1 (mitogen-activated protein kinase 1) /SLUG/vimentin feedback loop [82], whereas in melanoma and gastric cancer it acts as a tumor suppressor by targeting both SNAIL and MMP14 [83,84].